Anson Funds Management LP 13D/13G Filings for Oncolytics Biotech Inc. (ONCY)

Anson Funds Management LP 13D and 13G filings for Oncolytics Biotech Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
6:30 pm
Purchase
2024-12-31 13G Oncolytics Biotech Inc.
ONCY
Anson Funds Management LP 8,185,743
9.600%
8,185,743increase
(New Position)
Filing